| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/09/2009 | US20090093462 3-Arylamino pyridine derivatives |
| 04/09/2009 | US20090093461 Methods of Treating Anxiety and Mood Disorders |
| 04/09/2009 | US20090093460 Compositions |
| 04/09/2009 | US20090093459 2-alkoxy-3,4,5-trihydroxyalkylamide-benzothiazepines preparation thereof, compositions containing them and use thereof |
| 04/09/2009 | US20090093458 Methods of identifying anti-cancer agents and uses thereof |
| 04/09/2009 | US20090093457 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 04/09/2009 | US20090093456 Novel mch receptor antagonists |
| 04/09/2009 | US20090093455 Quinolone analogs and methods related thereto |
| 04/09/2009 | US20090093454 Chemical Compounds |
| 04/09/2009 | US20090093453 Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof |
| 04/09/2009 | US20090093452 Pyrrole, Thiophene, Furan, Imidazole, Oxazole, and Thiazole Derivatives |
| 04/09/2009 | US20090093451 IL-8 Receptor Antagonists |
| 04/09/2009 | US20090093450 Agent for inhibiting visceral fat accumulation |
| 04/09/2009 | US20090093449 dissolving azithromycin in an aqueous solution comprising a strong acid, and adding solution to sterilized solution comprising a strong base, wherein strong acid has a pKa less than -1.74; pulmonary infection, nasopharyngeal infection, otic infection, ocular infection, dermal or vaginal infections |
| 04/09/2009 | US20090093448 19-nor-progesterone for contraception |
| 04/09/2009 | US20090093447 Cddo-compounds and combination therapies thereof |
| 04/09/2009 | US20090093446 Method for alleviating keratoconjunctivitis sicca |
| 04/09/2009 | US20090093445 Release reagent for vitamin d compounds |
| 04/09/2009 | US20090093444 Cathepsin Cysteine Protease Inhibitors |
| 04/09/2009 | US20090093442 Uses of water-soluble cellulose derivatives for preventing or treating metabolic syndrome |
| 04/09/2009 | US20090093441 Preventing or reducing oxidative stress or oxidative cell injury |
| 04/09/2009 | US20090093440 Fragranced Therapeutic Delivery System |
| 04/09/2009 | US20090093439 RNA INTERFERENCE MEDIATED INHIBITION OF CHROMOSOME TRANSLOCATION GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 04/09/2009 | US20090093438 RNA INTERFERENCE MEDIATED INHIBITION OF XIAP GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 04/09/2009 | US20090093437 RNA INTERFERENCE MEDIATED INHIBITION OF CHECKPOINT KINASE-1 (CHK-1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 04/09/2009 | US20090093436 RNA INTERFERENCE MEDIATED INHIBITION OF VASCULAR CELL ADHESION MOLECULE (VCAM) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 04/09/2009 | US20090093435 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2 ASSOCIATED BINDING PROTEIN (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 04/09/2009 | US20090093434 Use of eif-5a1 sirna to protect islets cells from apoptosis and to preserve their functionality |
| 04/09/2009 | US20090093433 SENSE mRNA THERAPY |
| 04/09/2009 | US20090093432 Tumor inhibition by modulating sprouty expression or activity |
| 04/09/2009 | US20090093431 RNA INTERFERENCE MEDIATED INHIBITION OF NOGO AND NOGO RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 04/09/2009 | US20090093430 Biomarkers and methods for identification of agents useful in the treatment of affective disorders |
| 04/09/2009 | US20090093429 Combination therapy for treating cancer |
| 04/09/2009 | US20090093427 Articular Cartilage Gene Therapy with Recombinant Vector Encoding BMP-7 |
| 04/09/2009 | US20090093426 Rnai modulation of scap and therapeutic uses thereof |
| 04/09/2009 | US20090093425 Transducible delivery of nucleic acids by reversible phosphotriester charge neutralization protecting groups |
| 04/09/2009 | US20090093424 Markers for melanoma |
| 04/09/2009 | US20090093423 Such as 1-{[(2S,3S,5R)-2-Carboxy-3-methyl-4,4,7-trioxo-4-thia-1-azabicyclo[3.2.0]hept-3-yl]methyl}-3-methyl-1H-1,2,3-triazol-3-ium; beta-lactamase inhibitors |
| 04/09/2009 | US20090093422 Oxazolidinone derivatives and methods of use |
| 04/09/2009 | US20090093421 Administration of avermectin/milbemycin compounds for the treatment of ophthalmic pathologies |
| 04/09/2009 | US20090093420 Processes for the preparation of azithromycin |
| 04/09/2009 | US20090093419 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 04/09/2009 | US20090093418 Novel aminoglycosides and uses thereof in the treatment of genetic disorders |
| 04/09/2009 | US20090093417 angiotensin II type 1 (AT1) receptor antagonist activity and neprilysin inhibition activity; aryl compounds with both tert-amide and another tert or sec-amide group |
| 04/09/2009 | US20090093415 Therapeutic agent for irritable bowel syndrome |
| 04/09/2009 | US20090093414 methotrexate- alpha -PhePhe-NHC10H20O3NHCO O-hyaluronic acid; therapeutical agent; oseoarthritis (degenerative diseases ) |
| 04/09/2009 | US20090093396 Diagnostics and therapeutics for restenosis |
| 04/09/2009 | US20090093057 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 04/09/2009 | US20090092981 Tetrahydropyran nucleic acid analogs |
| 04/09/2009 | US20090092963 Method for combined parallel agent delivery and electroporation for cell structures an use thereof |
| 04/09/2009 | US20090092727 Water-dispersible phytosterol-surfactant conglomerate particles |
| 04/09/2009 | US20090092690 Process of making theaflavins enriched tea extract |
| 04/09/2009 | US20090092688 Ointment for topical treatment of hot flashes and method of use |
| 04/09/2009 | US20090092687 Prhormone composition and method of use thereof |
| 04/09/2009 | US20090092686 Process for the recovery of a phytolipid composition |
| 04/09/2009 | US20090092684 Small molecule antagonists of bcl-2 family proteins |
| 04/09/2009 | US20090092683 Micronized Wood Preservative Formulations |
| 04/09/2009 | US20090092672 Orally disintegrating tablet compositions of lamotrigine |
| 04/09/2009 | US20090092670 Long acting dual release product containing carbinoxamine and pseudoephedrine |
| 04/09/2009 | US20090092669 Stable imatinib compositions |
| 04/09/2009 | US20090092668 Acetaminophen formulation for joint pain relief |
| 04/09/2009 | US20090092667 Method for Reducing Amyloid Deposition, Amyloid Neurotoxicity, and Microgliosis with (-)-Nilvadipine Enantiomer |
| 04/09/2009 | US20090092665 OPHTHALMIC COMPOSITIONS COMPRISING CALCINEURIN INHIBITORS OR mTOR INHIBITORS |
| 04/09/2009 | US20090092663 Tumor-targeted drug delivery systems and uses thereof |
| 04/09/2009 | US20090092662 Liposome formulations of boronic acid compounds |
| 04/09/2009 | US20090092659 containing protonated/acidified nucleic acids that are bactericidal; wound sealant, surgical drape , skin substitute |
| 04/09/2009 | US20090092658 Novel formulations of proton pump inhibitors and methods of using these formulations |
| 04/09/2009 | US20090092657 Amino acid combinant omega oil aphrodisiac |
| 04/09/2009 | US20090092656 Method of treating atrophic vaginitis |
| 04/09/2009 | US20090092654 Drug Delivery Methods, Structures, and Compositions for Nasolacrimal System |
| 04/09/2009 | US20090092648 Antimicrobial polymer compositions and the use thereof |
| 04/09/2009 | US20090092647 Polyurethane foams for wound management |
| 04/09/2009 | US20090092646 Effigy and Compound to Affect Bird Behavior |
| 04/09/2009 | US20090092642 Skin and/or Hair Products, Containing Compounds With an Isoprenoid Structure |
| 04/09/2009 | US20090092641 Uses of natural immunobiotic extract |
| 04/09/2009 | US20090092640 Increased T-cell tumor infiltration and eradication of metastases by mutant LIGHT |
| 04/09/2009 | US20090092624 Antiinfective Flavononol Compounds and Methods of Use Thereof |
| 04/09/2009 | US20090092623 Promoter |
| 04/09/2009 | US20090092622 Molecules, compositions, methods and kits for applications associated with flaviviruses |
| 04/09/2009 | US20090092616 ZNF206: A Novel Regulator of Embryonic Stem Cell Self-renewal and Pluripotency |
| 04/09/2009 | US20090092611 Antibodies that bind both bcma and taci |
| 04/09/2009 | US20090092600 Methods and compositions relating to the regulation of muc1 by hsf1 and stat3 |
| 04/09/2009 | US20090092595 Suppression of sPLA2-integrin binding for treating an inflammatory condition |
| 04/09/2009 | US20090092594 Mammalian genes involved in viral infection and tumor suppression |
| 04/09/2009 | US20090092592 Methionyl tRNA Synthetase Polynucleotides |
| 04/09/2009 | US20090092590 Method for improving stool characteristics in infants |
| 04/09/2009 | US20090092589 Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains |
| 04/09/2009 | US20090092580 Dialkyl ether delivery agents |
| 04/09/2009 | US20090092576 Antifungal treatment of nails |
| 04/09/2009 | US20090092575 Ophthalmic compositions with a disuccinate |
| 04/09/2009 | US20090092574 Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof |
| 04/09/2009 | US20090092573 Method of manufacturing a nicotine delivery product |
| 04/09/2009 | US20090092560 Trivalent chromium compounds, compositions and methods of use |
| 04/09/2009 | US20090092558 6-Hydroxy-8-{1-hydroxy-2-[2-(p-alkoxy- or carboxyalkoxyphenyl)-1,1-dimethylethylamino]ethyl}4H-benzo[1,4]oxazin-3-ones, e.g., 6-hydroxy-8-{1-hydroxy-2-[2-(4-phenoxyacetic acid)-1,1-dimethylethylamino]- ethyl}-4H-benzo[1,4]oxazin-3-one; betamimetics |
| 04/09/2009 | US20090092557 Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use |
| 04/09/2009 | US20090092553 Monocarboxylate transporters expressed in cancer cells |
| 04/09/2009 | US20090092550 Porphyrin linked metronidazole against gum disease: porphyromonas gingivalis |
| 04/09/2009 | US20090092548 Methods And Compounds For Targeting Tissues |
| 04/09/2009 | US20090092547 Injectable Particles |
| 04/09/2009 | US20090092545 Antibodies that bind both bcma and taci |